Sumitovant Biopharma to take full ownership of Myovant Sciences for $1.7bn

Sumitovant Biopharma, a subsidiary of Japan-based Sumitomo Pharma (previously Sumitomo Dainippon Pharma), is set to take full ownership of Myovant Sciences, an American publicly-listed biopharma ... Read More